Vaccination Priorities in Travel.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 1, doi. 10.2165/00063030-200317001-00001
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2003 AND VI 17 AND IP 3
Results: 17
1
2
Immunisation against Hepatitis A, Hepatitis B and Typhoid Fever via Combined Vaccination.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 7, doi. 10.2165/00063030-200317001-00002
- By:
- Publication type:
- Article
3
Rapid Hepatitis B Immunisation for the Traveller.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 11, doi. 10.2165/00063030-200317001-00003
- By:
- Publication type:
- Article
4
Rapid Protection against Hepatitis A and B Using an Accelerated Vaccination Schedule 1 ®.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 15, doi. 10.2165/00063030-200317001-00004
- By:
- Publication type:
- Article
5
Rapid Protection and Vaccination against Hepatitis A for Travellers.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 19, doi. 10.2165/00063030-200317001-00005
- By:
- Publication type:
- Article
6
Current Status and Replies to Frequently Posed Questions on Atovaquone Plus Proguanil (Malarone[sup ®]) for the Prevention of Malaria.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 23, doi. 10.2165/00063030-200317001-00006
- By:
- Publication type:
- Article
7
Abetimus: Abetimus sodium, LJP 394.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 212
- Publication type:
- Article
8
Profile Summary.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 211, doi. 10.2165/00063030-200317030-00008
- Publication type:
- Article
9
Spotlight on Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 207, doi. 10.2165/00063030-200317030-00007
- By:
- Publication type:
- Article
10
Leucocyte Interferon-alpha for Patients with Chronic Hepatitis C Intolerant to Other alpha-Interferons.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 201, doi. 10.2165/00063030-200317030-00006
- By:
- Publication type:
- Article
11
Role of Novel Biological Therapies in Psoriatic Arthritis: Effects on Joints and Skin.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 187, doi. 10.2165/00063030-200317030-00005
- By:
- Publication type:
- Article
12
Probiotics and Inflammatory Bowel Disease.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 179, doi. 10.2165/00063030-200317030-00004
- By:
- Publication type:
- Article
13
Stealth Nucleosides: Mode of Action and Potential Use in the Treatment of Viral Diseases.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 169, doi. 10.2165/00063030-200317030-00003
- By:
- Publication type:
- Article
14
Gangliosides as Therapeutic Targets for Cancer.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 155, doi. 10.2165/00063030-200317030-00002
- By:
- Publication type:
- Article
15
T-Cell Depleting Antibodies: New Hope for Induction of Allograft Tolerance in Bone Marrow Transplantation?
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 147, doi. 10.2165/00063030-200317030-00001
- By:
- Publication type:
- Article
16
Gastrin 17 vaccine – Aphton: Anti-gastrin 17 immunogen, G17DT.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 223, doi. 10.2165/00063030-200317030-00011
- Publication type:
- Article
17
INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy – Introgen, RPR/INGN 201.
- Published in:
- BioDrugs, 2003, v. 17, n. 3, p. 216
- Publication type:
- Article